Cost effectiveness of telecare management for pain and depression in patients with cancer: Results from a randomized trial

Sung J. Choi Yoo, John A. Nyman, Andrea L Cheville, Kurt Kroenke

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: Pain and depression are prevalent and treatable symptoms among patients with cancer, yet they are often undetected and undertreated. The Indiana Cancer Pain and Depression (INCPAD) trial demonstrated that telecare management can improve pain and depression outcomes. This article investigates the incremental cost effectiveness of the INCPAD intervention. Methods: The INCPAD trial was conducted in 16 community-based urban and rural oncology practices in Indiana. Of the 405 participants, 202 were randomized to the intervention group and 203 to the usual-care group. Intervention costs were determined, and effectiveness outcomes were depression-free days and quality-adjusted life years. Results: The intervention group was associated with a yearly increase of 60.3 depression-free days (S.E.= 15.4; P<. 0.01) and an increase of between 0.033 and 0.066 quality-adjusted life years compared to the usual care group. Total cost of the intervention per patient was US$1189, which included physician, nurse care manager and automated monitoring set-up and maintenance costs. Incremental cost per depression-free day was US$19.72, which yields a range of US$18,018 to US$36,035 per quality-adjusted life year when converted to that metric. When measured directly, the incremental cost per quality-adjusted life year ranged from US$10,826 based on the modified EQ-5D to US$73,286.92 based on the SF-12. Conclusion: Centralized telecare management, coupled with automated symptom monitoring, appears to be a cost effective intervention for managing pain and depression in cancer patients.

Original languageEnglish (US)
Pages (from-to)599-606
Number of pages8
JournalGeneral Hospital Psychiatry
Volume36
Issue number6
DOIs
StatePublished - Nov 1 2014

Fingerprint

Pain Management
Cost-Benefit Analysis
Depression
Quality-Adjusted Life Years
Costs and Cost Analysis
Neoplasms
Pain
Nurses
Maintenance
Physicians

Keywords

  • Cancer
  • Cost-effectiveness
  • Depression
  • Pain
  • Telecare

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cost effectiveness of telecare management for pain and depression in patients with cancer : Results from a randomized trial. / Choi Yoo, Sung J.; Nyman, John A.; Cheville, Andrea L; Kroenke, Kurt.

In: General Hospital Psychiatry, Vol. 36, No. 6, 01.11.2014, p. 599-606.

Research output: Contribution to journalArticle

@article{9976ef1681c14caabc701db1785744e1,
title = "Cost effectiveness of telecare management for pain and depression in patients with cancer: Results from a randomized trial",
abstract = "Objective: Pain and depression are prevalent and treatable symptoms among patients with cancer, yet they are often undetected and undertreated. The Indiana Cancer Pain and Depression (INCPAD) trial demonstrated that telecare management can improve pain and depression outcomes. This article investigates the incremental cost effectiveness of the INCPAD intervention. Methods: The INCPAD trial was conducted in 16 community-based urban and rural oncology practices in Indiana. Of the 405 participants, 202 were randomized to the intervention group and 203 to the usual-care group. Intervention costs were determined, and effectiveness outcomes were depression-free days and quality-adjusted life years. Results: The intervention group was associated with a yearly increase of 60.3 depression-free days (S.E.= 15.4; P<. 0.01) and an increase of between 0.033 and 0.066 quality-adjusted life years compared to the usual care group. Total cost of the intervention per patient was US$1189, which included physician, nurse care manager and automated monitoring set-up and maintenance costs. Incremental cost per depression-free day was US$19.72, which yields a range of US$18,018 to US$36,035 per quality-adjusted life year when converted to that metric. When measured directly, the incremental cost per quality-adjusted life year ranged from US$10,826 based on the modified EQ-5D to US$73,286.92 based on the SF-12. Conclusion: Centralized telecare management, coupled with automated symptom monitoring, appears to be a cost effective intervention for managing pain and depression in cancer patients.",
keywords = "Cancer, Cost-effectiveness, Depression, Pain, Telecare",
author = "{Choi Yoo}, {Sung J.} and Nyman, {John A.} and Cheville, {Andrea L} and Kurt Kroenke",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.genhosppsych.2014.07.004",
language = "English (US)",
volume = "36",
pages = "599--606",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Cost effectiveness of telecare management for pain and depression in patients with cancer

T2 - Results from a randomized trial

AU - Choi Yoo, Sung J.

AU - Nyman, John A.

AU - Cheville, Andrea L

AU - Kroenke, Kurt

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Objective: Pain and depression are prevalent and treatable symptoms among patients with cancer, yet they are often undetected and undertreated. The Indiana Cancer Pain and Depression (INCPAD) trial demonstrated that telecare management can improve pain and depression outcomes. This article investigates the incremental cost effectiveness of the INCPAD intervention. Methods: The INCPAD trial was conducted in 16 community-based urban and rural oncology practices in Indiana. Of the 405 participants, 202 were randomized to the intervention group and 203 to the usual-care group. Intervention costs were determined, and effectiveness outcomes were depression-free days and quality-adjusted life years. Results: The intervention group was associated with a yearly increase of 60.3 depression-free days (S.E.= 15.4; P<. 0.01) and an increase of between 0.033 and 0.066 quality-adjusted life years compared to the usual care group. Total cost of the intervention per patient was US$1189, which included physician, nurse care manager and automated monitoring set-up and maintenance costs. Incremental cost per depression-free day was US$19.72, which yields a range of US$18,018 to US$36,035 per quality-adjusted life year when converted to that metric. When measured directly, the incremental cost per quality-adjusted life year ranged from US$10,826 based on the modified EQ-5D to US$73,286.92 based on the SF-12. Conclusion: Centralized telecare management, coupled with automated symptom monitoring, appears to be a cost effective intervention for managing pain and depression in cancer patients.

AB - Objective: Pain and depression are prevalent and treatable symptoms among patients with cancer, yet they are often undetected and undertreated. The Indiana Cancer Pain and Depression (INCPAD) trial demonstrated that telecare management can improve pain and depression outcomes. This article investigates the incremental cost effectiveness of the INCPAD intervention. Methods: The INCPAD trial was conducted in 16 community-based urban and rural oncology practices in Indiana. Of the 405 participants, 202 were randomized to the intervention group and 203 to the usual-care group. Intervention costs were determined, and effectiveness outcomes were depression-free days and quality-adjusted life years. Results: The intervention group was associated with a yearly increase of 60.3 depression-free days (S.E.= 15.4; P<. 0.01) and an increase of between 0.033 and 0.066 quality-adjusted life years compared to the usual care group. Total cost of the intervention per patient was US$1189, which included physician, nurse care manager and automated monitoring set-up and maintenance costs. Incremental cost per depression-free day was US$19.72, which yields a range of US$18,018 to US$36,035 per quality-adjusted life year when converted to that metric. When measured directly, the incremental cost per quality-adjusted life year ranged from US$10,826 based on the modified EQ-5D to US$73,286.92 based on the SF-12. Conclusion: Centralized telecare management, coupled with automated symptom monitoring, appears to be a cost effective intervention for managing pain and depression in cancer patients.

KW - Cancer

KW - Cost-effectiveness

KW - Depression

KW - Pain

KW - Telecare

UR - http://www.scopus.com/inward/record.url?scp=84919457908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919457908&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2014.07.004

DO - 10.1016/j.genhosppsych.2014.07.004

M3 - Article

C2 - 25130518

AN - SCOPUS:84919457908

VL - 36

SP - 599

EP - 606

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 6

ER -